CN108057021B - A kind of Montelukast sodium granules and preparation method thereof - Google Patents
A kind of Montelukast sodium granules and preparation method thereof Download PDFInfo
- Publication number
- CN108057021B CN108057021B CN201711430085.7A CN201711430085A CN108057021B CN 108057021 B CN108057021 B CN 108057021B CN 201711430085 A CN201711430085 A CN 201711430085A CN 108057021 B CN108057021 B CN 108057021B
- Authority
- CN
- China
- Prior art keywords
- montelukast
- granulation
- preparation
- corrigent
- montelukast sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711430085.7A CN108057021B (en) | 2017-12-25 | 2017-12-25 | A kind of Montelukast sodium granules and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711430085.7A CN108057021B (en) | 2017-12-25 | 2017-12-25 | A kind of Montelukast sodium granules and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108057021A CN108057021A (en) | 2018-05-22 |
CN108057021B true CN108057021B (en) | 2019-03-19 |
Family
ID=62140278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711430085.7A Active CN108057021B (en) | 2017-12-25 | 2017-12-25 | A kind of Montelukast sodium granules and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108057021B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110787133A (en) * | 2018-08-01 | 2020-02-14 | 北京万全德众医药生物技术有限公司 | Montelukast sodium granules and preparation process thereof |
CN111110679A (en) * | 2018-10-31 | 2020-05-08 | 长春海悦药业股份有限公司 | Pharmaceutical composition containing montelukast sodium |
CN112386578B (en) * | 2020-10-26 | 2022-11-22 | 石药集团欧意药业有限公司 | Montelukast sodium chewable tablet and preparation method thereof |
CN114652688B (en) * | 2020-12-23 | 2023-08-22 | 鲁南制药集团股份有限公司 | Montelukast sodium chewable tablet and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732268B (en) * | 2010-01-09 | 2012-12-05 | 鲁南制药集团股份有限公司 | Montelukast sodium tablet and preparation method thereof |
KR20140125492A (en) * | 2013-04-19 | 2014-10-29 | 주식회사 에스텍파마 | Granule composition containing sodium montelukast and its preparing method and chewable tablet |
JP6575031B2 (en) * | 2014-07-28 | 2019-09-18 | 日本ケミファ株式会社 | Montelukast sodium preparation |
-
2017
- 2017-12-25 CN CN201711430085.7A patent/CN108057021B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108057021A (en) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108057021B (en) | A kind of Montelukast sodium granules and preparation method thereof | |
JP5461179B2 (en) | Cellulosic micronucleus particles and method for producing the same | |
JP2017140515A (en) | Inhalable dry powders | |
TWI468190B (en) | (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | |
ES2317452T3 (en) | FORMULATIONS OF LEVETIRACETAM AND PROCEDURES FOR PREPARATION. | |
CN109310637A (en) | The production method of dosage form | |
Saigal et al. | Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension | |
JP2012532180A (en) | BIBW2992, a salt thereof and a method for drying a solid pharmaceutical preparation comprising this active ingredient | |
CN103610680B (en) | A kind of CEFUROXIME AXETIL composition and method of making the same | |
CN105213346B (en) | A kind of pharmaceutical composition and preparation method thereof containing cinacalcet hydrochloride | |
CN106999483B (en) | A kind of pharmaceutical composition containing quinoline or its salt | |
CA2428817C (en) | Copolyvidone-containing preparation | |
CN105832713B (en) | A kind of pharmaceutical composition and preparation method thereof comprising fluvoxamine maleate | |
CN109010301B (en) | Lacosamide crystal form II tablet and preparation method and application thereof | |
CN109310636A (en) | The production method of dosage form | |
CN107708737A (en) | The outer layer composition of solid pharmaceutical preparation and the easy taking solid pharmaceutical preparation containing the outer layer composition | |
KR20160000762A (en) | Composite formulation for oral administration comprising ezetimibe and rosuvastatin and a process for the preparation thereof | |
CN107167401A (en) | Levetiracetam sustained-release tablets pharmaceutical composition and its Quality Control and preparation method | |
CN106139156B (en) | A kind of pharmaceutical composition containing quinoline or its salt | |
CN103096880B (en) | The granule of the pastille film cladding that unpleasant taste is masked | |
CN102764254B (en) | A kind of levetiracetam medicinal composition and preparation method thereof | |
CN106551946A (en) | It is a kind of containing trifluorothymidine and hydrochloric acid for the pharmaceutical composition and preparation method than pyrimidine | |
CN103142541A (en) | Stable montelukast sodium capsule | |
CN105560202B (en) | A kind of preparation method and application of nalbuphlne hydrochloride gel skeleton sustained release tablets | |
CN110404079A (en) | A kind of not carbonate containing, the quinoline of low genotoxicity impurity content or the pharmaceutical composition of its salt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Montelukast sodium granules and preparation method thereof Effective date of registration: 20200311 Granted publication date: 20190319 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING KANGZHOU PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980000590 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221018 Granted publication date: 20190319 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING KANGZHOU PHARMACEUTICAL TECHNOLOGY CO.,LTD. Registration number: Y2020980000590 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Monrost Sodium Granule and Its Preparation Method Effective date of registration: 20230724 Granted publication date: 20190319 Pledgee: Zheshang Bank Co.,Ltd. Nanjing Branch Pledgor: NANJING KANGZHOU PHARMACEUTICAL TECHNOLOGY CO.,LTD. Registration number: Y2023980049596 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |